HAVCR2 and undifferentiated pleomorphic sarcoma: Our analysis indicates that patients with undifferentiated pleomorphic sarcomas (UPS), male gender, age ≥ 55 years and high expression of other immune markers (high TIL counts, positive PD-1 and PD-L1 expression) are more likely to demonstrate strong TIM-3 expression.